Developer docs
API playgroundTry for free, no card

Search company profiles

Truveta

Full company profile

uuid0000d2e

Namestring
Truveta
Legal namestring
Truveta Inc.
Websiteurl
truveta.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Truveta is a Bellevue, Washington-based healthcare data and AI platform founded in September 2020 by four US health systems (Providence, Advocate Health, Tenet Healthcare, Trinity Health) alongside co-founders Terry Myerson, Jay Nanduri, and Ryan Ahern. The company aggregates daily-refreshed, longitudinally linked electronic health record data from 30 US member health systems covering 130M+ patients — approximately 18% of all US clinical care across 40+ states — and combines it with closed claims, devices, genomics, images, social determinants of health, mother-child linkages, multiomics, and mortality data. This data asset underpins its core Truveta Data product, the Truveta Intelligence AI analytics layer (launched April 2026), the Trusted Research Environment for executing studies, Truveta Evidence Services for regulatory-grade study design, the Truveta Language Model for clinical text processing, Live Link for real-time data streams, and a Clinical Trials Solution for trial sponsors.

The company's revenue model is enterprise subscription-based with quote-driven pricing, anchored by Truveta Data subscriptions and complemented by professional services through Truveta Evidence Services. It serves four primary verticals: pharmaceutical companies (e.g., Moderna, Boehringer Ingelheim) for drug development, regulatory evidence, and post-market surveillance; medical device manufacturers (e.g., Boston Scientific) for post-market performance monitoring; healthcare provider organizations (the 30 member systems plus academic medical centers) for research and quality benchmarking; and public health agencies for disease surveillance and health equity analysis. Go-to-market is direct enterprise field sales supplemented by partnerships — most notably a strategic alliance with Microsoft for Azure infrastructure and Cloud for Healthcare integration, and a 2026 collaboration with Knit Health on clinical behavior modeling. The company has raised approximately $320 million in venture funding across multiple rounds, achieving a $1 billion unicorn valuation in January 2025 with a consortium of health system members plus strategic investors including Illumina and Regeneron.

Short descriptiontext

Truveta is a healthcare data and AI platform that aggregates daily-refreshed longitudinal EHR data from 30 US health systems covering 130M+ patients, selling regulatory-grade real-world evidence subscriptions to pharmaceutical, medical device, healthcare, and public health organizations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
real-world health data, EHR data platform, healthcare analytics software, clinical research data, regulatory-grade evidence
Industry5 codes
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACABAB
HIE Platforms & Network Services (Community/Regional/National)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAHAC
Quality Measurement, Reporting & Benchmarking (HEDIS/Stars/CQM)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
SECONDARYHLAJAJAM
Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
SECONDARYHLAJAJAK
Healthcare Utilization, Claims & Administrative Data Analytics
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
NAICS code3 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
  • Information51
SIC code4 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Computer Processing & Data Preparation7374
  • Services-Health Services8000
  • Services-Prepackaged Software7372
Product category
Real-World Health Data Platform
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Truveta Data Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to regulatory-grade real-world health data platform covering 130M+ patients. Customers include life sciences organizations, healthcare systems, and public health agencies that pay for access to data, analytics, and intelligence capabilities.

truveta.com
2Evidence Services
TypeProfessional Services
Description

Expert-led study design, execution, and evidence generation services for regulatory submissions and post-market studies. Includes access to scientific expertise for regulatory-grade evidence.

globenewswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise subscription with customized data access and analytics capabilities
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; not publicly disclosed. Access levels vary by customer type (life sciences, healthcare, public health) and data requirements.

truveta.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Truveta Data
Description

A complete, living view of patient care covering 130M+ patients with longitudinal data including EHR, claims, devices, images, SDOH, mother-child, multiomics, and mortality data.

truveta.com
+4 more records
Core offering1 text field

Truveta provides a real-world health data platform that aggregates longitudinal EHR data from 30 US member health systems covering 130M+ patients, refreshed daily. On top of this data, Truveta offers an AI-powered analytics environment (Truveta Intelligence), a trusted research environment for regulatory-grade evidence generation, expert-led study services, and a clinical trials solution. The platform serves life sciences, healthcare, and public health customers through subscription access and professional services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Clinical questions answered in minutes vs months
+3 more records
Product overview1 text field

Truveta offers a unified healthcare data platform built with and owned by US health systems, consisting of Truveta Data as the foundational core product providing longitudinal EHR data on 130M+ patients, complemented by Truveta Intelligence (AI-powered real-time insights), Truveta Evidence (trusted research environment and evidence services), Truveta Language Model, Live Link, and a Clinical Trials Solution. The platform connects real-time insight with regulatory-grade validation, serving life sciences, public health, and healthcare organizations across the drug development and care delivery lifecycle.

Product and service5 records
1Truveta Data
CategoryReal-world health data
Description

A complete, real-time view of US healthcare providing longitudinally linked EHR, closed claims, devices, images, SDOH, mother-child, multiomics, genomics, and mortality data covering 130M+ patients and updated daily. Sold as a subscription data foundation for life sciences, healthcare, and public health customers.

2Truveta Intelligence
CategoryAI analytics software
Description

AI-powered platform that lets users ask natural-language questions about patients, treatments, and outcomes and receive real-time insights backed by full methodology transparency (Verify). Available to Truveta Data subscribers across life sciences, public health, and healthcare organizations.

3Truveta Evidence (Trusted Research Environment)
CategoryResearch environment software
Description

Secure research environment providing immediate access to Truveta Data for executing full research studies, with dynamic cohort refinement using reusable, clinically precise definitions and audit-ready evidence aligned to regulatory standards.

4Truveta Evidence Services
CategoryProfessional services
Description

Expert-led study design and evidence generation service that extends customer capacity with scientific experts, accelerates timelines from protocol to submission, and de-risks high-impact regulatory and post-market studies.

5Truveta Clinical Trials Solution
CategoryClinical trials software
Description

Clinical trials solution enabling sponsors to design, optimize, and execute clinical studies using real-time, daily-refreshed real-world data, with site-level visibility, real-time patient identification, continuous enrollment monitoring, and external control arms.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-12
Description

Collaboration announced May 12, 2026 to develop next-generation clinical AI by combining Truveta's regulatory-grade real-world clinical data covering 130M+ patients with Knit's Large Clinical Behavior Model trained on actual clinical decision-making. Aims to improve patient care through specialist routing optimization, predictive patient flow management, and care pathway optimization.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-09-29
Description

Strategic partnership announced September 2021 to leverage Microsoft Azure and AI for health data analysis and research. Partnership aims to scale Truveta's health data platform globally and accelerate healthcare insights with focus on health equity and data privacy. Truveta's platform integrates into Microsoft Cloud for Healthcare to enhance healthcare offerings.

Strategic tierCoreTypeOthers
Description

Founding member health system that helped create Truveta. CEO Rod Hochman originally conceived the idea in 2018. Providence is part of the 30-member health system consortium that owns and powers Truveta.

Strategic tierCoreTypeOthers
Description

Founding member health system and co-founder of Truveta in September 2020. One of the 30 health systems powering the platform.

Strategic tierCoreTypeOthers
Description

Founding member health system and co-founder of Truveta in September 2020. One of the 30 health systems powering the platform.

Strategic tierCoreTypeOthers
Description

Founding member health system and co-founder of Truveta in September 2020. One of the 30 health systems powering the platform.

Strategic tierCoreTypeOthers
Description

Member health system in Truveta consortium. Part of the 30 health systems powering the platform representing over 18% of US clinical care.

Strategic tierCoreTypeOthers
Description

Member health system in Truveta consortium. Part of the 30 health systems powering the platform.

Strategic tierCoreTypeOthers
Description

Member health system in Truveta consortium. Part of the 30 health systems powering the platform.

10Baylor Scott & White Health
Strategic tierCoreTypeOthers
Description

Member health system in Truveta consortium. Part of the 30 health systems powering the platform.

truveta.com
Strategic tierCoreTypeOthers
Description

Member health system in Truveta consortium. Part of the 30 health systems powering the platform.

Strategic tierMinorTypeOthers
Description

Pfizer's Chief Safety Officer, Dr. Patrick Caubel, serves on Truveta's Board of Directors.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborated on peer-reviewed research published in JAMA Network Open on heart failure follow-up care gaps, along with Yale New Haven Hospital and Duke University School of Medicine.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborated on peer-reviewed research on heart failure published in JAMA Network Open alongside Yale School of Medicine and Yale New Haven Hospital.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic collaboration on TrajOnco multi-agent LLM framework research with co-author Prof. Meliha Yetisgen.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic collaboration on TrajOnco cancer risk prediction research with co-author Dr. Ruth Etzioni.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research collaboration on LLM-based clinical information extraction published at IJCAI 2025 and MedInfo 2025.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Flatiron Health is a real-world evidence platform focused on oncology, aggregating EHR data from oncology clinics and selling RWE to life sciences customers. Now owned by Roche, it is the most direct comparator to Truveta's pharma-facing RWD/RWE model, especially in oncology and clinical research.

2Tempus AI
TypeDirect peer
Description

Tempus AI combines multi-omic clinical data (EHR, genomics, imaging, pathology) with an AI library to serve life sciences, providers, and payers. Its data-and-AI stack overlaps with Truveta's longitudinal EHR plus Truveta Intelligence play.

TypeDirect peer
Description

Komodo Health operates a healthcare data map linking claims, EHR, and other sources to power RWE, patient journey, and commercial analytics for life sciences. It competes head-on with Truveta for pharma RWE spend, with a broader claims backbone versus Truveta's EHR backbone.

TypeDirect peer
Description

ConcertAI provides real-world evidence and AI solutions for oncology and clinical research, drawing on EHR-linked data from provider networks. Its provider-network model and pharma RWE focus closely mirror Truveta's positioning.

TypeDirect peer
Description

TriNetX operates a global health research network that links EHR data from member health systems for clinical trial design, site identification, and real-world studies. Its consortium model and life sciences customer base are highly comparable to Truveta's.

TypeBroad incumbent
Description

IQVIA is the largest clinical research and real-world data company, combining R&D services, technology, and proprietary data assets for pharma. It is a broader incumbent offering overlapping RWE capabilities but as part of a much larger CRO and technology portfolio.

TypeBroad incumbent
Description

Health Catalyst is a healthcare analytics and data platform serving providers and life sciences with quality, cost, and outcomes analytics. It overlaps with Truveta on provider-facing analytics and value-based care use cases but lacks Truveta's pharma-focused RWE focus.

TypeEmerging player
Description

Atropos Health focuses on generating real-world evidence from electronic health record data using AI-driven analytics for clinical and research questions. It overlaps with Truveta's Truveta Intelligence and evidence-generation workflow but at an earlier stage and with narrower data scale.

TypeEmerging player
Description

Datavant provides health data connectivity and de-identification, enabling linking of EHR, claims, and other patient-level data. It is an emerging player in the same ecosystem, with overlapping customers in life sciences and adjacent infrastructure rather than direct RWE competition.

TypeBroad incumbent
Description

Epic's Cosmos aggregates de-identified EHR data across participating health systems for population health and research use. As the dominant EHR vendor, Epic competes with Truveta's consortium model from a position of installed-base strength and could expand Cosmos into the RWE use cases Truveta serves.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors20 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Truveta

Real-World Health Data Platformtruveta.com

Truveta is a healthcare data and AI platform that aggregates daily-refreshed longitudinal EHR data from 30 US health systems covering 130M+ patients, selling regulatory-grade real-world evidence subscriptions to pharmaceutical, medical device, healthcare, and public health organizations.

What Truveta does

Truveta is a Bellevue, Washington-based healthcare data and AI platform founded in September 2020 by four US health systems (Providence, Advocate Health, Tenet Healthcare, Trinity Health) alongside co-founders Terry Myerson, Jay Nanduri, and Ryan Ahern. The company aggregates daily-refreshed, longitudinally linked electronic health record data from 30 US member health systems covering 130M+ patients — approximately 18% of all US clinical care across 40+ states — and combines it with closed claims, devices, genomics, images, social determinants of health, mother-child linkages, multiomics, and mortality data. This data asset underpins its core Truveta Data product, the Truveta Intelligence AI analytics layer (launched April 2026), the Trusted Research Environment for executing studies, Truveta Evidence Services for regulatory-grade study design, the Truveta Language Model for clinical text processing, Live Link for real-time data streams, and a Clinical Trials Solution for trial sponsors.

The company's revenue model is enterprise subscription-based with quote-driven pricing, anchored by Truveta Data subscriptions and complemented by professional services through Truveta Evidence Services. It serves four primary verticals: pharmaceutical companies (e.g., Moderna, Boehringer Ingelheim) for drug development, regulatory evidence, and post-market surveillance; medical device manufacturers (e.g., Boston Scientific) for post-market performance monitoring; healthcare provider organizations (the 30 member systems plus academic medical centers) for research and quality benchmarking; and public health agencies for disease surveillance and health equity analysis. Go-to-market is direct enterprise field sales supplemented by partnerships — most notably a strategic alliance with Microsoft for Azure infrastructure and Cloud for Healthcare integration, and a 2026 collaboration with Knit Health on clinical behavior modeling. The company has raised approximately $320 million in venture funding across multiple rounds, achieving a $1 billion unicorn valuation in January 2025 with a consortium of health system members plus strategic investors including Illumina and Regeneron.

Truveta firmographics

Firmographics
Name
Truveta
Legal name
Truveta Inc.
Website
https://truveta.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
251–500 employees
Short description
Truveta is a healthcare data and AI platform that aggregates daily-refreshed longitudinal EHR data from 30 US health systems covering 130M+ patients, selling regulatory-grade real-world evidence subscriptions to pharmaceutical, medical device, healthcare, and public health organizations.
Ownership category
akta.pro rank

Truveta industry classification

Industry
Product category
Real-World Health Data Platform
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Information (51)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374), Services-Health Services (8000), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACABAB
HIE Platforms & Network Services (Community/Regional/National)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAHAC
Quality Measurement, Reporting & Benchmarking (HEDIS/Stars/CQM)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
SECONDARYHLAJAJAM
Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
SECONDARYHLAJAJAK
Healthcare Utilization, Claims & Administrative Data Analytics
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics

Keywords

  • Real-world health data
  • EHR data platform
  • Healthcare analytics software
  • Clinical research data
  • Regulatory-grade evidence

Where Truveta is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Truveta business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Truveta Data Subscriptions: Subscription-based access to regulatory-grade real-world health data platform covering 130M+ patients. Customers include life sciences organizations, healthcare systems, and public health agencies that pay for access to data, analytics, and intelligence capabilities.
  2. Evidence Services: Expert-led study design, execution, and evidence generation services for regulatory submissions and post-market studies. Includes access to scientific expertise for regulatory-grade evidence.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription with customized data access and analytics capabilities

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Truveta product offering

Product offering

Core offering

Truveta provides a real-world health data platform that aggregates longitudinal EHR data from 30 US member health systems covering 130M+ patients, refreshed daily. On top of this data, Truveta offers an AI-powered analytics environment (Truveta Intelligence), a trusted research environment for regulatory-grade evidence generation, expert-led study services, and a clinical trials solution. The platform serves life sciences, healthcare, and public health customers through subscription access and professional services.

Product overview

Truveta offers a unified healthcare data platform built with and owned by US health systems, consisting of Truveta Data as the foundational core product providing longitudinal EHR data on 130M+ patients, complemented by Truveta Intelligence (AI-powered real-time insights), Truveta Evidence (trusted research environment and evidence services), Truveta Language Model, Live Link, and a Clinical Trials Solution. The platform connects real-time insight with regulatory-grade validation, serving life sciences, public health, and healthcare organizations across the drug development and care delivery lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

  • Truveta Data: A complete, living view of patient care covering 130M+ patients with longitudinal data including EHR, claims, devices, images, SDOH, mother-child, multiomics, and mortality data.
  • Truveta Intelligence
  • Truveta Evidence Services
  • Truveta Language Model
  • TrajOnco

Products and services

  • Truveta Data A complete, real-time view of US healthcare providing longitudinally linked EHR, closed claims, devices, images, SDOH, mother-child, multiomics, genomics, and mortality data covering 130M+ patients and updated daily. Sold as a subscription data foundation for life sciences, healthcare, and public health customers.
  • Truveta Intelligence AI-powered platform that lets users ask natural-language questions about patients, treatments, and outcomes and receive real-time insights backed by full methodology transparency (Verify). Available to Truveta Data subscribers across life sciences, public health, and healthcare organizations.
  • Truveta Evidence (Trusted Research Environment) Secure research environment providing immediate access to Truveta Data for executing full research studies, with dynamic cohort refinement using reusable, clinically precise definitions and audit-ready evidence aligned to regulatory standards.
  • Truveta Evidence Services Expert-led study design and evidence generation service that extends customer capacity with scientific experts, accelerates timelines from protocol to submission, and de-risks high-impact regulatory and post-market studies.
  • Truveta Clinical Trials Solution Clinical trials solution enabling sponsors to design, optimize, and execute clinical studies using real-time, daily-refreshed real-world data, with site-level visibility, real-time patient identification, continuous enrollment monitoring, and external control arms.

Quantifiable outcome

  • Clinical questions answered in minutes vs months
  • +3 more outcomes

Companies that use Truveta

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Truveta technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature9 records

Truveta partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and minor.

  • Knit HealthcoreStrategic or Co-development Partner · 12 May 2026Collaboration announced May 12, 2026 to develop next-generation clinical AI by combining Truveta's regulatory-grade real-world clinical data covering 130M+ patients with Knit's Large Clinical Behavior Model trained on actual clinical decision-making. Aims to improve patient care through specialist routing optimization, predictive patient flow management, and care pathway optimization.
  • MicrosoftcoreStrategic or Co-development Partner · 29 September 2021Strategic partnership announced September 2021 to leverage Microsoft Azure and AI for health data analysis and research. Partnership aims to scale Truveta's health data platform globally and accelerate healthcare insights with focus on health equity and data privacy. Truveta's platform integrates into Microsoft Cloud for Healthcare to enhance healthcare offerings.
  • Providence HealthcoreOthersFounding member health system that helped create Truveta. CEO Rod Hochman originally conceived the idea in 2018. Providence is part of the 30-member health system consortium that owns and powers Truveta.
  • Advocate HealthcoreOthersFounding member health system and co-founder of Truveta in September 2020. One of the 30 health systems powering the platform.
  • Tenet HealthcarecoreOthersFounding member health system and co-founder of Truveta in September 2020. One of the 30 health systems powering the platform.
  • Trinity HealthcoreOthersFounding member health system and co-founder of Truveta in September 2020. One of the 30 health systems powering the platform.
  • Northwell HealthcoreOthersMember health system in Truveta consortium. Part of the 30 health systems powering the platform representing over 18% of US clinical care.
  • AdventHealthcoreOthersMember health system in Truveta consortium. Part of the 30 health systems powering the platform.
  • CommonSpirit HealthcoreOthersMember health system in Truveta consortium. Part of the 30 health systems powering the platform.
  • Baylor Scott & White HealthcoreOthersMember health system in Truveta consortium. Part of the 30 health systems powering the platform.
  • Bon Secours Mercy HealthcoreOthersMember health system in Truveta consortium. Part of the 30 health systems powering the platform.
  • PfizerminorOthersPfizer's Chief Safety Officer, Dr. Patrick Caubel, serves on Truveta's Board of Directors.
  • Yale School of MedicineminorStrategic or Co-development PartnerCollaborated on peer-reviewed research published in JAMA Network Open on heart failure follow-up care gaps, along with Yale New Haven Hospital and Duke University School of Medicine.
  • Duke University School of MedicineminorStrategic or Co-development PartnerCollaborated on peer-reviewed research on heart failure published in JAMA Network Open alongside Yale School of Medicine and Yale New Haven Hospital.
  • University of WashingtonminorStrategic or Co-development PartnerAcademic collaboration on TrajOnco multi-agent LLM framework research with co-author Prof. Meliha Yetisgen.
  • Fred Hutch Cancer CenterminorStrategic or Co-development PartnerAcademic collaboration on TrajOnco cancer risk prediction research with co-author Dr. Ruth Etzioni.
  • Iowa State UniversityminorStrategic or Co-development PartnerAcademic research collaboration on LLM-based clinical information extraction published at IJCAI 2025 and MedInfo 2025.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Truveta competitors and assessment

Company assessment

Direct peers

  • Flatiron Health: Flatiron Health is a real-world evidence platform focused on oncology, aggregating EHR data from oncology clinics and selling RWE to life sciences customers. Now owned by Roche, it is the most direct comparator to Truveta's pharma-facing RWD/RWE model, especially in oncology and clinical research.
  • Tempus AI: Tempus AI combines multi-omic clinical data (EHR, genomics, imaging, pathology) with an AI library to serve life sciences, providers, and payers. Its data-and-AI stack overlaps with Truveta's longitudinal EHR plus Truveta Intelligence play.
  • Komodo Health: Komodo Health operates a healthcare data map linking claims, EHR, and other sources to power RWE, patient journey, and commercial analytics for life sciences. It competes head-on with Truveta for pharma RWE spend, with a broader claims backbone versus Truveta's EHR backbone.
  • ConcertAI: ConcertAI provides real-world evidence and AI solutions for oncology and clinical research, drawing on EHR-linked data from provider networks. Its provider-network model and pharma RWE focus closely mirror Truveta's positioning.
  • TriNetX: TriNetX operates a global health research network that links EHR data from member health systems for clinical trial design, site identification, and real-world studies. Its consortium model and life sciences customer base are highly comparable to Truveta's.

Broad incumbents

  • IQVIA: IQVIA is the largest clinical research and real-world data company, combining R&D services, technology, and proprietary data assets for pharma. It is a broader incumbent offering overlapping RWE capabilities but as part of a much larger CRO and technology portfolio.
  • Health Catalyst: Health Catalyst is a healthcare analytics and data platform serving providers and life sciences with quality, cost, and outcomes analytics. It overlaps with Truveta on provider-facing analytics and value-based care use cases but lacks Truveta's pharma-focused RWE focus.
  • Epic Systems (Cosmos): Epic's Cosmos aggregates de-identified EHR data across participating health systems for population health and research use. As the dominant EHR vendor, Epic competes with Truveta's consortium model from a position of installed-base strength and could expand Cosmos into the RWE use cases Truveta serves.

Emerging players

  • Atropos Health: Atropos Health focuses on generating real-world evidence from electronic health record data using AI-driven analytics for clinical and research questions. It overlaps with Truveta's Truveta Intelligence and evidence-generation workflow but at an earlier stage and with narrower data scale.
  • Datavant: Datavant provides health data connectivity and de-identification, enabling linking of EHR, claims, and other patient-level data. It is an emerging player in the same ecosystem, with overlapping customers in life sciences and adjacent infrastructure rather than direct RWE competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights7 records

Customer concentration

Truveta social profiles

Digital presence

Truveta financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Truveta leadership team

Management profile

Number of profiles

Profiles9 records

Truveta funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors20 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Truveta M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Truveta

What does Truveta do?

Truveta provides a real-world health data platform that aggregates longitudinal EHR data from 30 US member health systems covering 130M+ patients, refreshed daily. On top of this data, Truveta offers an AI-powered analytics environment (Truveta Intelligence), a trusted research environment for regulatory-grade evidence generation, expert-led study services, and a clinical trials solution. The platform serves life sciences, healthcare, and public health customers through subscription access and professional services.

Is Truveta a public or private company?

Truveta is a private company. It is classified as venture growth investor backed and is currently operating.

When was Truveta founded?

Truveta was founded in 2020. It employs 251 to 500 people.

Where is Truveta based?

Truveta is headquartered in Seattle, United States, in the North America region.

How does Truveta make money?

Two revenue lines are on record. Truveta Data Subscriptions are the primary driver. The others are evidence Services.

Who are Truveta's main competitors?

Direct peers on record are Flatiron Health, Tempus AI, Komodo Health, ConcertAI and TriNetX. Broad incumbents are IQVIA, Health Catalyst and Epic Systems (Cosmos). Emerging players are Atropos Health and Datavant.

Does Truveta have an API?

Yes. Truveta offers access to its platform through Truveta Studio (https://studio.truveta.com), a research platform for conducting studies. Users can sign up for accounts and access the platform programmatically. The API allows life sciences, public health, and healthcare organizations to query real-world patient data and generate evidence.

What industry is Truveta in?

Truveta's product category is Real-World Health Data Platform. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms, with a secondary code of HLACABAB, HIE Platforms & Network Services (Community/Regional/National). Its NAICS code is 51821 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialTruveta Launches Care Insights Solution To Inform Pre-Launch Planning, Then Follow Treatments After Approval And Into Clinical PracticeTruveta launched a care insights solution using daily de-identified EHR data from over 140 million U.S. patients to track treatment patterns. Research found 65% of non-diabetic patients discontinued GLP-1 therapy within a year, and 95% of patients lacked documented pain management for IUD insertion in 2025.GlobeNewswireTruveta launches care insights solution to inform pre-launch planning, then follow treatments after approval and into clinical practiceTruveta launched a care insights solution using daily de-identified EHR data from over 140 million U.S. patients to track treatment patterns. Research found 65% of non-diabetic patients discontinued GLP-1 therapy within a year, and 95% of patients lacked documented pain management for IUD insertion.FinancialContent Business PageTruveta launches care insights solution to inform pre-launch planning, then follow treatments after approval and into clinical practiceTruveta launched a care insights solution using de-identified EHR data from over 140 million U.S. patients to track treatment patterns. Research found 65% of non-diabetic patients discontinued GLP-1 therapy within a year, and 95% of patients lacked documented pain management for IUD insertion in 2025.EIN PresswireKids’ ER Visits Due to E-Bikes Have Jumped Dramatically New Study FindsA Truveta study found emergency room visits for e-bike injuries among children and adolescents rose 1,810% and overall 760% from January 2023 to August 2026. Researchers linked the surge to increased e-bike use and rental availability. NYC Mayor Mamdani took legal action against 42 online retailers selling illegal high-speed e-bikes.EIN PresswireE-bike ER visits skyrocket 760% with child injuries up over 1,800%Emergency room visits for e-bike incidents rose 760% from January 2023 to August 2026, with child injuries up 1,800%, according to Truveta data. New York City proposed 23 micromobility bills, including Priscilla's Law, while e-bike collisions in NYC increased over 30% this year.New York PostE-bike-related emergency room visits soar 760% in three years — and 1,810% for kids: studyEmergency room visits tied to e-bike injuries rose 760% overall and 1,810% for children between January 2023 and August 2026, according to Truveta data. The 4,769 e-bike-related visits dwarfed traditional bicycle visits, with head and neck injuries most common. Researchers noted possible differences in helmet use, riding locations, or behavior.HealthlineMenopause: Off-Label Prescriptions for Women on the RiseTestosterone prescriptions for women nearly tripled, rising 146% from January 2023 to July 2026, according to a Truveta analysis. No FDA-approved female-specific products exist, causing access delays and denials. The FDA called for more data on female testosterone therapy on September 17.GeekWireTerry Myerson retires as Truveta CEO, with co-founders stepping in to lead $1B health data startupTerry Myerson is retiring as CEO of Truveta at the end of September, with co-founders Jay Nanduri and Ryan Ahern stepping in as interim co-CEOs. The Bellevue-based health data company, valued over $1 billion, pools de-identified patient records from 30 U.S. health systems. Myerson will become an advisor, and the board is searching for a permanent CEO.FinancialContent Business PageTruveta CEO Terry Myerson announces retirementTerry Myerson announced his retirement as CEO of Truveta, effective immediately, after six and a half years. Co-founders Jay Nanduri and Ryan Ahern will serve as interim co-CEOs while the board searches for a successor. The transition comes as Truveta enters its next phase of growth.New York PostParents refusing crucial shots for newborns as babies’ life-threatening bleeding risks increaseUS newborns not receiving vitamin K at birth rose to 8.1% by June 2026, up from 5.2% six months earlier, according to Truveta data. The CDC says babies without the shot are 81 times more likely to have life-threatening bleeding in the first six months, and one in five such cases is fatal.